- Professor of Health Policy and Management
Credentials & Experience
Education & Training
- M Phil, 2000 Columbia University
- PhD, 2001 Columbia University
Committees, Societies, Councils
Research Associate, National Bureau of Economic Research
Steering Committee, NBER Innovation Information Initiative
Steering Committee, Columbia University Precision Medicine and Society Program
Honors & Awards
2002-3. Faculty Member of the Year Teaching Award (School of Public Policy, Georgia Institute of Technology)
2001-2. Faculty Member of the Year Teaching Award (School of Public Policy, Georgia Institute of Technology)
2001. Dissertation "Essays on the Economics of University Patenting" Awarded Distinction (Columbia University, Graduate School of Arts and Sciences)
1996. Sanford Parker Award in Economics. (Columbia College, Columbia University)
1996. B.A. awarded with honors, summa cum laude. Elected to Phi Beta Kappa. (Columbia College, Columbia University)
Robert Wood Johnson Foundation Investigator Award
- Global Health
- Healthcare Policy
Mowery,David C.,Richard R.Nelson, Bhaven N.Sampat, and Arvids A.Ziedonis.Ivory Tower and Industrial Innovation: University-Industry Technology Transfer Before and After Bayh-Dole.Stanford: Stanford University Press,1994.
Gross, Daniel P., and Bhaven N. Sampat. Crisis Innovation Policy from World War II to COVID-19. Entrepreneurship and Innovation Policy and the Economy. National Bureau of Economic Research (2021)
Sampat, Bhaven N., and Kenneth C. Shadlen. "The COVID-19 Innovation System" Health Affairs 40.3 (2021): 400-409.
Sampat, Bhaven N., and Heidi L. Williams. "How do patents affect follow-on innovation? Evidence from the human genome." American Economic Review 109 (2019): 203-36.
Azoulay, Pierre, Graff-Zivin, Joshua, Li, Danielle, and Bhaven N. Sampat "Public R&D investments and private-sector patenting: evidence from NIH funding rules." The Review of Economic Studies 86 (2019): 117-152.
Li, Danielle, Pierre Azoulay, and Bhaven N. Sampat. "The applied value of public investments in biomedical research." Science (2017): 78-81.
Hegde, Deepak, and Bhaven Sampat. "Can private money buy public science? Disease group lobbying and federal funding for biomedical research." Management Science 61.10 (2015): 2281-2298.
Hemphill, C. Scott, and Bhaven N. Sampat. "Evergreening, patent challenges, and effective market life in pharmaceuticals." Journal of health economics 31.2 (2012): 327-339.
Sampat, Bhaven N., and Frank R. Lichtenberg. "What are the respective roles of the public and private sectors in pharmaceutical innovation?." Health Affairs 30.2 (2011): 332-339.